UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Shingles vaccines likely to become cheaper
With local shingles vaccines rolled out, the prices of shingles vaccines ar...
by So Jae-hyeon
|
2018-10-22 17:05
라인
Bayer’s blood thinner wins broader indication for coronary artery disease
Bayer Korea said it has obtained approval for an expanded indication for Xa...
by Nam Doo-hyun
|
2018-10-19 16:34
라인
Listed pharmaceuticals’ operating margins decline to 12.2 pct. in H1
The operating profit to sales ratio of 110 pharmaceutical companies listed ...
by Lee Hye-seon
|
2018-10-19 14:20
라인
Seegene to speed up advances into China
Seegene said Friday that it has signed a business agreement with Xi'an ...
by Lee Han-soo
|
2018-10-19 11:46
라인
Novo Nordisk Korea releases research results for rapid-acting insulin
Novo Nordisk Korea said Thursday said that it has presented the results of ...
by Lee Han-soo
|
2018-10-18 17:22
라인
Trivalent flu shots out of stock, quadrivalent products selling poorly
Pharmaceutical companies aggressively marketed new quadrivalent flu vaccine...
by So Jae-hyeon
|
2018-10-18 13:59
라인
Developing natural product-derived drugs gets trickier under Nagoya Protocol
Korean pharmaceutical companies are struggling to develop new drugs out of ...
by So Jae-hyeon
|
2018-10-18 12:00
라인
Theragen Etex promotes gene sequencing feat in US conference
Theragen Etex said Monday the company is promoting its gene sequencing acco...
by Lee Han-soo
|
2018-10-17 16:45
라인
CrystalGenomics hopes to test new leukemia drug early next year
CrystalGenomics said it hoped to carry out a phase-1 clinical trial on new ...
by Nam Doo-hyun
|
2018-10-16 16:17
라인
Drug regulator raids 4 cell therapy makers
The pharmaceutical industry is paying keen attention to why the Ministry of...
by So Jae-hyeon
|
2018-10-16 15:28
라인
Chong Kun Dang recruits European researchers for autoimmune disease drug
Chong Kun Dang said Monday that it has gathered European clinical researche...
by Lee Han-soo
|
2018-10-16 12:08
라인
‘AI-based drug development to broaden gap between pharmaceuticals’
Local pharmaceutical firms should brace for a new era where drugmakers take...
by So Jae-hyeon
|
2018-10-15 15:37
라인
[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink
The medical community and pharmaceutical industry have raised suspicion tha...
by So Jae-hyeon
|
2018-10-15 14:52
라인
Sanofi-Aventis Korea unveils sub-analysis for dyslipidemia therapy
Sanofi-Aventis Korea said Friday that it has published the results of ODYSS...
by Lee Han-soo
|
2018-10-12 17:25
라인
Abbvie’s hepatitis C drug expands indication
Abbvie’s Maviret, a hepatitis C treatment, has received approval for additi...
by Lee Han-soo
|
2018-10-12 15:40
라인
[News Focus] Celltrion to accelerate US entry on imminent FDA approval
Cellrion is expected to accelerate its move to enter the U.S. market with a...
by So Jae-hyeon
|
2018-10-12 15:40
라인
Bridge Bio completes phase-1 study for ulcerative colitis drug in US
Bridge Biotherapeutics said Friday that it has completed phase-1 clinical t...
by Lee Han-soo
|
2018-10-12 13:38
라인
Boryung to export anticancer drugs to Philippine
Boryung Pharmaceutical said Friday that it has signed a deal with Endure Me...
by Lee Han-soo
|
2018-10-12 13:26
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon
|
2018-10-11 16:33
라인
YD Life Science wins source tech for anti-cancer gene therapy
YD Life Science said Wednesday that it has signed a technology transfer agr...
by Lee Han-soo
|
2018-10-11 14:46
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top